Cosmo Pharmaceuticals says its Phase 3 trials of topical clascoterone for male-pattern hair loss showed statistically ...

The median earnings for tech workers residing in King County hit $163,600 last year, an increase of around $63,000 since 2015 ...

UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...

Intracardiac echocardiography is noninferior to TEE for prevention of thromboembolic complications in patients receiving ablation for AF.

Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more ...

The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates, including KOR ...

The Food and Drug Administration has granted Breakthrough Therapy designation to zilganersen for the treatment of Alexander disease.

Families are increasingly seeking nonmedical exemptions to routine childhood vaccines, making communities more vulnerable to preventable diseases.

Continuous positive airway pressure (CPAP) termination rates among patients with OSA are affected by geographic disparities.

Increased intake of non-steroidal anti-inflammatory drugs is tied to reduced radiographic spinal progression in patients with ...

Analysts at Jefferies see blockbuster potential in zorevunersen in Dravet syndrome, with sales potentially reaching $1 ...

Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy ...